A method of producing analgesia in a mammal is provided by rotational (alternating) intrathecal administration to the mammal of a pharmaceutically effective dose of at least one opioid receptor agonist, such as a .mu.-, .delta.-, or .kappa.-opioid receptor agonist for a first period of time, followed by intrathecal administration to the mammal of a pharmaceutically effective dose of at least one opioid receptor-like receptor 1 (ORL-1) agonist for a second period of time. The intrathecal drug administration of the first and second periods of time may be repeated a plurality of times without attaining tolerance in the mammal to either drug. Implantable apparatus for rotational administration of the active agents is also disclosed.

 
Web www.patentalert.com

< Animal models of long QT syndrome and uses thereof

< Medical device components

> 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof

> Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors

~ 00615